• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在欧洲经济区对医疗技术和医疗用品进行监管。

Regulating healthcare technologies and medical supplies in the European Economic Area.

作者信息

Altenstetter C

机构信息

Graduate School and University Center of the City University of New York, NY 10036, USA.

出版信息

Health Policy. 1996 Jan;35(1):33-52. doi: 10.1016/0168-8510(95)00771-7.

DOI:10.1016/0168-8510(95)00771-7
PMID:10172644
Abstract

A complex relationship exists among EU regulations, current national practices and rules, institutional capacities to implement regulatory adjustments and the legacy of past health and regulatory policy and traditions. However, there is little empirical information on medical devices policy, the medical devices industry, and the assurance of medical device safety and usage. Drawing on a review of the secondary literature and on-going field work, the evidence suggests that the current mix of state-centric and self-regulatory traditions will be as important in determining the implementation and final outcomes of EU-rules as the new rules themselves. EU directives redesign rules, but they do not necessarily lead to institutional change, create manpower, skills and institutional capacities, or alter governance and administrative practices in the short term. Neither EU directives nor national regulatory adjustments determine the 'man-machine/skills-experience' interface which is shaped and influenced by local medical traditions and the acceptance of these traditions by local publics.

摘要

欧盟法规、当前各国的做法和规则、实施监管调整的机构能力以及过去卫生和监管政策及传统的遗留问题之间存在着复杂的关系。然而,关于医疗器械政策、医疗器械行业以及医疗器械安全与使用保障的实证信息却很少。根据对二手文献的回顾和正在进行的实地调研,有证据表明,当前以国家为中心的传统与自我监管传统的结合,在决定欧盟规则的实施和最终结果方面,将与新规则本身同样重要。欧盟指令重新设计规则,但它们不一定会导致机构变革、创造人力、技能和机构能力,也不一定会在短期内改变治理和行政做法。欧盟指令和国家监管调整都无法决定“人机/技能-经验”界面,该界面是由当地医疗传统以及当地公众对这些传统的接受程度所塑造和影响的。

相似文献

1
Regulating healthcare technologies and medical supplies in the European Economic Area.在欧洲经济区对医疗技术和医疗用品进行监管。
Health Policy. 1996 Jan;35(1):33-52. doi: 10.1016/0168-8510(95)00771-7.
2
Single-market regulation and innovation in Europe's medical devices industry.欧洲医疗器械行业的单一市场监管与创新
Int J Technol Assess Health Care. 2001 Summer;17(3):421-32. doi: 10.1017/s0266462301106136.
3
Medical device regulation for manufacturers.针对制造商的医疗器械监管
Proc Inst Mech Eng H. 2003;217(6):459-67. doi: 10.1243/09544110360729090.
4
EU and member state medical devices regulation.欧盟及成员国医疗器械法规
Int J Technol Assess Health Care. 2003 Winter;19(1):228-48. doi: 10.1017/s0266462303000217.
5
Regulating the economic evaluation of pharmaceuticals and medical devices: a European perspective.规范药品和医疗器械的经济评估:欧洲视角
Health Policy. 2003 Feb;63(2):167-78. doi: 10.1016/s0168-8510(02)00063-5.
6
Medical device regulations and testing for toxicologic pathologists.医疗设备法规与毒理病理学家的检测
Toxicol Pathol. 2008 Jan;36(1):63-9. doi: 10.1177/0192623307309926.
7
Harmonising and competing for medicines regulation: how healthy are the European Union's systems of drug approval?药品监管的协调与竞争:欧盟药品审批体系的健康状况如何?
Soc Sci Med. 1999 Jun;48(11):1655-67. doi: 10.1016/s0277-9536(99)00042-8.
8
[Drugs in the European Union: the health-market complex].[欧盟的药品:健康市场综合体]
Gac Sanit. 2005 Mar-Apr;19(2):151-67. doi: 10.1157/13074370.
9
The reimbursement of the expenses for medical treatment received by 'transnational' patients in EU-countries.欧盟国家中“跨国”患者接受医疗治疗费用的报销情况。
Health Policy. 1995 Jul;33(1):43-57. doi: 10.1016/0168-8510(94)00681-4.
10
"Trade creep" and implications of the Transatlantic Trade and Investment Partnership Agreement for the United Kingdom National Health Service.“贸易渗透”和《跨大西洋贸易与投资伙伴关系协定》对英国国民保健制度的影响。
Int J Health Serv. 2014;44(1):93-111. doi: 10.2190/HS.44.1.f.

引用本文的文献

1
Confusion over whether new technologies should be regulated at European or state level.对于新技术应在欧洲层面还是国家层面进行监管存在困惑。
BMJ. 1996 Dec 7;313(7070):1486-7. doi: 10.1136/bmj.313.7070.1486c.